论文部分内容阅读
An attractive alternative in bone tissue engineering is to harness the potential of endogenous stem/progenitor cells for direct use in repair and regeneration.This strategy can effectively avoid the limitations such as rejection response,sources limitation,high cost,and high mortality of exogenous stem cells after transplantation in vivo[1].